Table: OncoTherapy Science - 6-MTH group results

OncoTherapy Science

09/11/2018 07:30

Nov 9 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            24 mln              201 mln                    
                 (-87.9 pct)        (+485.7 pct)                  
  Operating       loss 1.73           loss 1.43                   
  Recurring       loss 1.73           loss 1.42                   
  Net             loss 1.54           loss 1.37                   
  EPS          loss 10.49 yen       loss 9.30 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T